Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease

Aaron Waxman discusses research into patients with pulmonary hypertension due to interstitial lung disease and the effects of inhaled treprostinil.  Aaron B. Waxman is the director of the Pulmonary Vascular Disease Program at Brigham and Women’s Hospital (BWH). He is also an associate professor of medicine at Harvard Medical School.

Image courtesy of Aaron Waxman

Image courtesy of the interviewee


Report Infringement

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Article

Tipping Point for Online Learning?

Next Article

Assessing the Assessment

×
As a Guest, you have insight(s) remaining for this month. Create a free account to view 300 more annually.
Related Posts
error:

Add the Faculti Web App to your Mobile or Desktop homescreen

Install
×